Tudorza Pressair is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). It belongs to a class of drugs known as long-acting anticholinergics, which work by relaxing the muscles in the airways to improve breathing.
This medication comes in the form of a dry powder inhaler, making it easy and convenient to use. Tudorza Pressair is typically taken twice daily, with each dose providing 400 mcg of aclidinium bromide.
It is important to follow the dosing instructions provided by your healthcare provider to ensure you are getting the maximum benefit from Tudorza Pressair. It is not a rescue inhaler and should not be used to treat sudden breathing problems.
Before starting Tudorza Pressair, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. Some common side effects of Tudorza Pressair may include dry mouth, cough, and headache. If you experience any severe or persistent side effects, be sure to contact your healthcare provider.
Overall, Tudorza Pressair can be an effective treatment option for individuals with COPD, helping to improve lung function and reduce symptoms such as shortness of breath and coughing. If you have been prescribed Tudorza Pressair, be sure to use it as directed and follow up with your healthcare provider regularly to monitor your progress.
EN 
ES 
FR 
PT 
ZH